Related references
Note: Only part of the references are listed.Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine Compared to Those of a 7-Valent Pneumococcal Conjugate Vaccine Given as a Three-Dose Series with Routine Vaccines in Healthy Infants and Toddlers
Susanna Esposito et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Tamara Pilishvili et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age A Double-blind Randomized Active-controlled Trial
Matthew D. Snape et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine
Kristina A. Bryant et al.
PEDIATRICS (2010)
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers
Sylvia H. Yeh et al.
PEDIATRICS (2010)
The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007
Julie A. Bettinger et al.
VACCINE (2010)
Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany
Dorothee M. Kieninger et al.
VACCINE (2010)
Changing Epidemiology of Invasive Pneumococcal Disease in Canada, 1998-2007: Update from the Calgary-Area Streptococcus pneumoniae Research (CASPER) Study
James D. Kellner et al.
CLINICAL INFECTIOUS DISEASES (2009)
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
Katherine L. O'Brien et al.
LANCET (2009)
Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials
Roman Prymula et al.
LANCET (2009)
Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis
Heather E. Hsu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Empyema associated with community-acquired pneumonia: A Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study
Joanne M. Langley et al.
BMC INFECTIOUS DISEASES (2008)
Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population
Marc G. Romney et al.
CLINICAL INFECTIOUS DISEASES (2008)
Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine
Stephen I. Pelton et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Effectiveness of pneumococcal conjugate vaccine in greater Vancouver Canada: 2004-20,05
Gordean Bjornson et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002
B Beall et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
CG Whitney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine
SB Black et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
S Black et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Share Paper
